EGID Monothematic Conference

General Information

General Information

Eosinophilic gastrointestinal diseases (EGIDs) are rare chronic, inflammatory disorders of the gastrointestinal (GI) tract with unknown longterm consequences. They comprise of eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), eosinophilic gastroenteritis (EGE) and eosinophilic colitis (EC). EoE is the most common and the best described EGID compared to EG, EGE and EC.  The clinical presentation of different EGIDs depends on the involved GI site as well as the extent and the depth of eosinophilic infiltration through the bowel wall.

In the absence of biological markers, the diagnosis is based on clinical symptoms and on histological findings of eosinophilic inflammation, after the exclusion of a secondary cause of inflammation or a systemic disorder, which is often a challenging issue given the absence of strict histological criteria for the EGIDs (beyond the esophagus) diagnosis. Treatment strategies depend on the involved site of the GI tract, maintenance therapy is often necessary to avoid relapses, while novel drugs are beeing developed for refractory disease. Due to the complexity of these disorders, the investigation and management of patients with EGIDs are often perplexing.
The Monothematic Conference on EGIDs will include invited lectures with physical presence of the speakers and few through web, as well as interactive sessions with cases presentations. The faculty comprise international experts in the field with different backgrounds and specific interests, aiming at enlightening different aspects of this challenging topic in order to aid clinicians of different specialties dealing with patients with EGIDs, to interpret the clinical manifestations and the laboratory findings of different EGIDs and to choose the best available treatment option, decreasing variations in clinical practice and improving effectiveness and quality of care.
The course language is English.

COVID-19 Information

COVID-19 has proven challenging in the organisation of onsite courses in the past year. ESPGHAN remains dedicated to the realisation of our educational programme without compromising the health of our delegates.
We are carefully monitoring the developments and follow the recommendations and information provided by the national Health Authorities, the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC). Preparations for an onsite course are proceeding as planned at this point. Applicants will be updated on any potential changes to the format of the school.
As the number of participants is a critical part in the planning and realisation of our schools, we encourage all interested HCPs to apply. If the situation does not allow for the responsible realisation of onsite participation, your application will be valid for virtual participation. Registration fees will be reimbursed or adapted accordingly. 
For more information please contact the ESPGHAN Office.

Registration & Fees

Application will open in 2021.

Application Deadline: TBC
Registration fees:
TBC Trainee member 
TBC ESPGHAN member Regular 
TBC Non-ESPGHAN member 

Kindly use the online application form on this page. Applications submitted by email cannot be accepted. If you experience any issues with the tool, please contact us at office@espghanCandidates will be selected based on a supporting letter from a Full ESPGHAN member and an abstract that may be selected for presentation during the course. Abstracts may have been submitted to other public meetings previously.

Please do not make travel arrangements before receipt of a formal confirmation of acceptance from the ESPGHAN Office. The number of participants is limited and a selection will be made by the school organisers after the deadline. Priority will be given to ESPGHAN Members.


Preliminary Programme

Day 01 - Thursday, November 04

08.45 - 09.00   Welcome
09.10 - 09.30   The role of eosinophils in the GI dysfunction:  are they key players or are they merely biomarkers?
09.30 - 10.00   Oral immunotherapy induced esophageal eosinophilia - lessons to be learned
10.00 - 10.30   Epidemiology, clinical presentation and endoscopic findings in chilhood EoE 
10.30 - 11.00   Histological findings in EoE. Histology scoring system EoEHSS
11.00 - 11.30   Coffee break
11.30 - 12.00   Non invasive diagnostic tools in EoE: can they replace endoscopy?
12.00 - 12.30   Online lecture: Esophageal dysmotility in EoE: which goes first?
12.30 - 13.00   The use of high resolution manometry, mucosal impedance and Endoflip in the diagnosis and follow up of EoE
13.00 - 14.00   Lunch
14.00 - 14.30   Dietary or drug treatment for induction in EoE? How to choose the best treatment for the individual patient?
14.30 - 15.00   Individualized approach to maintenance treatment: how and for how long?
15.30 - 16.00   Novel treatment modalities for resistant EoE
16.00 - 16.30   Coffee break
16.30 - 17.00   EoE in patients with esophageal atresia: how common is it and how its treatment affects the underlying disease?
17.00 - 17.30   Online lectures: Pathogenetic mechanisms of EoE, EG, EGE and EC: similarities and differences
17.30 - 18.30   Clinical cases discussion - interactive
Three cases - 20 min each case

19.00 Dinner 

Day 02 - Friday, November 05

09.00 - 09.30   Epidemiology, clinical presentation and endoscopic findings in childhood EGID beyond EoE
09.30 - 10.00   Initial work up of patients with suspected EGID beyond the esophagus
10.00 - 10.30   The role of US, MRI, MRE, C/S and of full thickness biopsy in diagnosing muscular and serosal EGID phenotypes
10.30 - 11.00   Histological criteria for diagnosing EGID beyond the esophagus
11.00 - 11.30   Coffee-break
11.30 - 12.00   Eosinophilic colitis: can we always be certain about the diagnosis? Signs and symptoms suggesting IBD 
12.00 - 12.30   Hypereosinophilic syndrome: how easy it is to differentiate from EGIDs?  Criteria for its diagnosis
12.30 - 13.00   Parasitic infections of the gut and eosinophilic infiltration: is the diagnosis always easy? 
13.00 - 13.30   Lunch
13.30 - 14.00   Connective Tissue Diseases. Associations with EGIDs 
14.00 - 14.30   Eosinophil activation in Functional Gastrointestinal Disorders
14.30 - 15.00   Elimination diets for treating EGIDs : which diet for which patient and for how long?
15.00 - 15.30   Drug treatment for induction in EGIDs
15.30 - 16.00   Treatment strategies for maintenance in EGID
16.00 - 16.30   Coffee break
16.30 - 17.00   Drug treatment beyond induction in EGIDs
17.00 - 17.30   Online lecture: Novel therapies for refractory or resistant disease
17.30 - 18.00   Atopic comorbidities in patients with EGIDs: how do they affect the management? 
18.00 - 18.30   Unmet needs of patients with EGIDs. Patient-Reported Outcomes are necessary
18.30 - 19.30   Clinical cases discussion - interactive
Three cases - 20 min each case

19.30 Farewell dinner

Day 03 - Saturday, November 06

09.00 - 10.00   ESPGHAN Guidelines on EoE 2020
10.00 - 11.00   Three different Guidelines on EoE (UEG, AGA, ESPGHAN): do they differ, where and why?
11.00 - 11.30   ESPGHAN/NASPGHAN and Invited experts Guidelines on EGIDs (Alexandra Papadopoulou)
11.30 - 12.00   Course assessment
12.00               Departure


coming soon.

Cost Coverage

ESPGHAN will arrange and cover the following for registered delegates: 

  • Dinners and social programme  (arranged by ESPGHAN)
  • Accommodation for up to 3 nights (arranged by ESPGHAN)
  • Catering throughout the course   
  • Course Material 


If you have any questions, please contact the ESPGHAN Office for details.
Phone: +41 (0)22 9000 401